Top Suppliers:I want be here
Related CAS#:
359600-11-6 98961-95-6
57671-49-5 1095823-51-0
57740-64-4 606144-35-8
297756-38-8 1955523-12-2
84277-82-7 1318758-34-7

5534-95-2

5534-95-2 structure
5534-95-2 structure
  • Name: Pentagastrin
  • Chemical Name: pentagastrin
  • CAS Number: 5534-95-2
  • Molecular Formula: C37H49N7O9S
  • Molecular Weight: 767.891
  • Catalog: API Diagnostic medication Organ function test agent
  • Create Date: 2018-02-19 08:00:00
  • Modify Date: 2026-07-01 02:16:34
  • pentagastrin is a synthetic polypeptide that has effects like gastrin when given parenterally，which can cause the secretion and synthesis of salivary proteins.[1]In vivo: WIN55, 212-2, which is a non-selective cannabinoid agonist decreased gastric acid secretion stimulated by pentagastrin (10 mg/kg, i.v.) in anaesthetized rats.[2]The effect of curcumin administered i.g. in a dose of 50 mg/kg on the pentagastrin (250 ?g/kg)-stimulated gastric acid output in rats with chronic gastric fistula. [3]
Name pentagastrin
Synonyms petogasrin
N-(tert-Butoxycarbonyl)-β-alanyl-L-tryptophyl-L-methionyl-L-α-aspartyl-L-phenylalaninamide
T-BOC-BETA-ALA-TRP-MET-ASP-PHE-NH2
Methotrexate &alpha
ici50123
n-t-butyloxycbonyl-beta-alanyl-l-tryptophyl-l-methionyl-l-asptyl-l-phenyla
Boc-β-ala-try-met-asp-phe(nh2)
l-n-tert-butyleste
HS71A
pentagastrine
PENTAGASTRIN SYNTHETIC
(10S,13S,16S)-10-((1H-Indol-3-yl)methyl)-16-(((S)-1-amino-1-oxo-3-phenylpropan-2-yl)cbamoyl)-2,2-dimethyl-13-(2-(methylthio)ethyl)-4,8,11,14-tetraoxo-3-oxa-5,9,12,15-tetraazaoctadecan-18-oic acid
n-[n-[n-[n-(n-tert-butoxycbonyl-beta-alanyl)-l-tryptophanyl]-l-methionyl]-l
Z-N-methyl-L-glutamic acid &gamma
Z-L-beta-Glutamic acid &gamma
MFCD00076515
BOC-BETA-ALA-TRP-MET-ASP-PHE-NH2
n-((1,1-dimethylethoxy)carbonyl)-beta-alanyl-l-tryptophyl-l-phenylalaninamid
L-Glutamic Acid &alpha
PENTAGASTRIN //BP
N-{[(2-Methyl-2-propanyl)oxy]carbonyl}-β-alanyl-L-tryptophyl-L-methionyl-L-α-aspartyl-L-phenylalaninamide
Fmoc-N-methyl-L-glutamic acid &gamma
Cholecystokinin-7(swine), 3-[N-[(1,1-dimethylethoxy)carbonyl]-b-alanine]- (9CI)
l-methionyl-l-alpha-asptyl
tert-butylester
Fmoc-L-alpha-aminoadipic acid &delta
Boc-b-Ala-Trp-Met-Asp-Phe-NH2
GRP
Boc-(β-Ala13)-Gastrin
Pehtagastrin
ptavlon
ay6608
Pentagastrin, 10 mM in DMSO
EINECS 226-889-7
Peptavlon
n-t-boc-β-ala-trp-met-asp-phe amide
PENTAGASTRIN
N-T-BOC-BETA-ALA-TRP-MET-ASP-PHE AMIDE
N-Carboxy-b-alanyl-L-tryptophyl-L-methionyl-L-aspartylphenyl-L-alaninamide N-tert-Butyl Ester
lanineamide
N-tert-Butyloxycbonyl-L-asptic Acid &beta
N-(1,1-Dimethylethoxy)carbonyl-βAla-L-Trp-L-Met-L-Asp-L-Phe-NH2
asptyl]-l-phenylalaninamide
BOC-β-Ala-Trp-Met-Asp-Phe-NH2
boc-beta-ala-try-met-asp-phe(nh2)
N-T-boc-B-ala-trp-met-asp-phe amide
N-(Benzyloxycbonyl)-L-glutamic Acid &alpha
ylpropionamido]-4-(methylthio)butyramido]succinamicacidn-tert-butylester
Fmoc-L-asptic Acid &beta
n-(alpha-cbamoylphenethyl)-3-[2-[2-[3-(cboxyamino)propionamido]-3-indol-3
Boc-b-Ala-Try-Met-Asp-Phe(NH2)
Acetyl-L-glutamic acid &gamma
n-cboxy-beta-alanyl-l-tryptophyl-l-methionyl-l-asptylphenyl-alaninamid
Gastrodiagnost
L-Phenylalaninamide, N-[(1,1-dimethylethoxy)carbonyl]-β-alanyl-L-tryptophyl-L-methionyl-L-α-asptyl
n-cboxy-beta-alanyl-l-tryptophyl-l-methionyl-l-asptylphenyl-l-alaninamiden
GASTRIN RELEASING PTIDE
N-Carboxy-β-alanyl-L-tryptophyl-L-methionyl-L-aspartylphenyl-L-alaninamide N-tert-butyl ester
petavlon
Pentagastrin, (HPLC)
DL-Glutamic acid &gamma
N-[N-[N-[N-(N-tert-Butoxycarbonyl-b-alanyl)-L-tryptophanyl]-L-methionyl ]-L-aspartyl]-L-phenylalaninamide
N-Boc-βAla-L-Trp-L-Met-L-Asp-L-Phe-NH2
N-(a-Carbamoylphenethyl)-3-[2-[2-[3-(carboxyamino)propionamido]-3-indol-3-ylpropionamido]-4-(methylthio)butyramido]succinamic Acid-N-tert-Butyl Ester
N-[(1,1-Dimethylethoxy)carbonyl]-b-alanyl-L-tryptophyl-L-methionyl-L-a-aspartyl-L-phenylalaninamide
gastrodiagnost
AY 6608, ICI 50123, NSC 367746, Boc-(b-Ala13)-Gastrin , Boc-b-Ala-CCK-4
Description pentagastrin is a synthetic polypeptide that has effects like gastrin when given parenterally，which can cause the secretion and synthesis of salivary proteins.[1]In vivo: WIN55, 212-2, which is a non-selective cannabinoid agonist decreased gastric acid secretion stimulated by pentagastrin (10 mg/kg, i.v.) in anaesthetized rats.[2]The effect of curcumin administered i.g. in a dose of 50 mg/kg on the pentagastrin (250 ?g/kg)-stimulated gastric acid output in rats with chronic gastric fistula. [3]
Related Catalog
References

[1]. Loy F et al. Ultrastructural evidence of a secretory role for melatonin in the human parotid gland.J Physiol Pharmacol, 2015 Dec, 66(6):847-53.

[2]. Abdel-Salam O et al. Gastric acid inhibitory and gastric protective effects of Cannabis and cannabinoids. Asian Pac J Trop Med, 2016 May, 9(5):413-9.

[3]. Czekaj R et al. Role of curcumin in protection of gastric mucosa against stress-induced gastric mucosal damage. Involvement of hypoacidity, vasoactive mediators and sensory neuropeptides. J Physiol Pharmacol, 2016 Apr, 67(2):261-75.
Density 1.3±0.1 g/cm3
Boiling Point 1196.6±65.0 °C at 760 mmHg
Melting Point 229-230° (dec)
Molecular Formula C37H49N7O9S
Molecular Weight 767.891
Flash Point 677.5±34.3 °C
Exact Mass 767.331238
PSA 276.21000
LogP 3.03
Vapour Pressure 0.0±0.3 mmHg at 25°C
Index of Refraction 1.604
Storage condition -20°C

CHEMICAL IDENTIFICATION

RTECS NUMBER :
AY2970000
CHEMICAL NAME :
Alaninamide, N-carboxy-beta-alanyl-L-tryptophyl-L-methionyl-L-aspa rtylphenyl-, N-tert-butyl ester, L-
CAS REGISTRY NUMBER :
5534-95-2
LAST UPDATED :
199612
DATA ITEMS CITED :
9
MOLECULAR FORMULA :
C37-H49-N7-O9-S
MOLECULAR WEIGHT :
767.99

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Human - man
DOSE/DURATION :
5 ug/kg
TOXIC EFFECTS :
Kidney, Ureter, Bladder - interstitial nephritis
REFERENCE :
BMJOAE British Medical Journal. (British Medical Assoc., BMA House, Tavistock Sq., London WC1H 9JR, UK) V.1- 1857- Volume(issue)/page/year: 289,470,1984
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
>100 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970- Volume(issue)/page/year: 4,90,1973
TYPE OF TEST :
LD - Lethal dose
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
>1 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
FATOAO Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- Volume(issue)/page/year: 38,612,1975
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
>300 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) Volume(issue)/page/year: 6,766,1982
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
50 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) Volume(issue)/page/year: 6,776,1982
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
>1 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970- Volume(issue)/page/year: 4,90,1973
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
>1 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970- Volume(issue)/page/year: 4,90,1973
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
>1 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) Volume(issue)/page/year: 6,766,1982
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
>150 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) Volume(issue)/page/year: 6,766,1982
Hazard Codes T
Risk Phrases 61-36/38-20/21
Safety Phrases S53-S45-S36/37/39-S22
RIDADR NONH for all modes of transport
WGK Germany 1
RTECS AY2970000
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.

Chemsrc provides CAS#:5534-95-2 MSDS, density, melting point, boiling point, structure, formula, molecular weight, synthetic route, etc.
title: CAS No. 5534-95-2 | Chemsrc address: https://m.chemsrc.com/en/baike/416064.html

Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer

Copyright © 2026 ChemSrc All Rights Reserved